30.7 F
Indianapolis
Tuesday, January 19, 2021

TAG

candidate

Lilly licenses PDL type 1 diabetes drug candidate

PDL BioPharma Inc. said Monday that Eli Lilly & Co. is licensing its drug candidate teplizumab, an experimental treatment for newly diagnosed type 1...
- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected

16,331FansLike
3,142FollowersFollow
5,989FollowersFollow
14SubscribersSubscribe

Latest news

Improving health care for Black women

Poetic justice?

Institutional racism is real

- Advertisement -
Español + Translate »
Skip to content